Research Article: PLP Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Introduction:
Gliomas are typically the most prevalent brain tumors, with glioblastoma (GBM) being the most aggressive and common malignant glioma. As such, a comprehensive investigation of GBM pathogenesis and identification of significant biomarkers would greatly aid in the diagnosis and treatment of this disease.
Read more